Why is Oxygenta Pharma falling/rising?

As of 12-Aug, Oxygenta Pharmaceutical Ltd is experiencing a decline in its stock price, currently at Rs 93.60, which represents a decrease of Rs 6.4 or 6.4%. The stock has underperformed its sector by 6.78% today, touching an intraday low of Rs 93.55. Additionally, the stock has shown a significant decline over the past week and month, with returns of -7.92% and -17.13%, respectively. Although the stock has performed well year-to-date with a gain of 7.01% and an impressive 152.97% increase over the past year, the recent trends indicate a drop in investor participation, as evidenced by a 38.13% decrease in delivery volume compared to the 5-day average. There is no information available regarding positive or negative factors impacting the stock. Broader market context indicates that while Oxygenta has outperformed the Sensex significantly over the longer term, its recent short-term performance is starkly contrasting, with the benchmark index only declining by 0.59% over the past week. This suggests that the broader market is not experiencing the same level of distress as Oxygenta, highlighting a specific issue with the company rather than a general market downturn. The stock's moving averages indicate a mixed performance, being higher than the 200-day moving average but lower than the shorter-term averages, which may further reflect investor uncertainty in the stock's immediate prospects.